EBMT 2019 | Regulatory qualification for the EBMT patient registry for CAR T-cell therapy

Christian Chabannon

Christian Chabannon, MD, PhD, of Institut Paoli-Calmettes, Marseille, France, discusses CAR T-cell therapy, particularly the regulatory qualification from the European Medicines Agency (EMA). Prof. Chabannon was speaking at the European Society for Blood and Marrow Transplantation (EBMT) 2019 Annual Meeting, held in Frankfurt, Germany.

Share this video